Thomas K. Equels - Nov 30, 2022 Form 4 Insider Report for AIM ImmunoTech Inc. (AIM)

Role
CEO & President, Director
Signature
/s/ Thomas K. Equels
Stock symbol
AIM
Transactions as of
Nov 30, 2022
Transactions value $
$0
Form type
4
Date filed
12/2/2022, 03:50 PM
Previous filing
Jul 18, 2022
Next filing
Jan 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AIM Options Award $0 +300K $0.00 300K Nov 30, 2022 Common Stock 300K $0.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options issued pursuant to employment agreement with Reporting Person.